Drug Pricing: Takeaways From the Chicago Medicaid Drug Rebate Program Summit

At the conclusion of one of the year’s major drug pricing conferences, Christopher H. Schott and Daniel Machado share their observations and key takeaways, including remarks by government speakers and the new #Medicaid regulation that CMS recently released, in the latest episode of Connected With Latham.